Stock Research: Penumbra

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Penumbra

NYQ:PEN US70975L1070
49
  • Value
    1
  • Growth
    98
  • Safety
    Safety
    91
  • Combined
    77
  • Sentiment
    16
  • 360° View
    360° View
    49
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Penumbra, Inc. is a thrombectomy company focused on developing technologies for challenging medical conditions by removing blood clots. Its main businesses include developing, manufacturing, and marketing novel products for conditions such as ischemic stroke, venous thromboembolism, acute limb ischemia, and acute coronary syndrome. The company operates in the United States, Europe, Canada, and Australia. In the last fiscal year, the company had 4500 employees, a market cap of $9155 million, profits of $755 million, and revenue of $1195 million.

more
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P MIDCAP
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 7 8 11
Growth
98 77 89 81
Safety
Safety
91 98 85 85
Sentiment
16 79 87 84
360° View
360° View
49 91 70 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
13 69 55 88
Opinions Change
50 21 50 75
Pro Holdings
n/a 75 60 10
Market Pulse
92 95 97 87
Sentiment
16 79 87 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 7 8 11
Growth
98 77 89 81
Safety Safety
91 98 85 85
Combined
77 81 57 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
9 16 17 28
Price vs. Earnings (P/E)
5 15 20 12
Price vs. Book (P/B)
17 27 26 28
Dividend Yield
1 1 1 1
Value
1 7 8 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
73 61 62 43
Profit Growth
91 94 100 100
Capital Growth
96 45 48 63
Stock Returns
74 59 79 71
Growth
98 77 89 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
72 82 68 77
Refinancing
48 22 7 11
Liquidity
95 98 13 13
Safety Safety
91 98 85 85

Similar Stocks

Discover high‑ranked alternatives to Penumbra and broaden your portfolio horizons.

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

Mosaic

NYQ:MOS
Country: USA
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Labcorp

NYQ:LH
Country: USA
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: